About Metabolon
Metabolon is a company based in Morrisville (United States) founded in 2000.. Metabolon has raised $165.87 million across 19 funding rounds from investors including Sumitomo Corporation, ARE and East West Bank. Metabolon has completed 2 acquisitions, including Lipomics and Metabolomic Discoveries. Metabolon offers products and services including Bioinformatics Platform, Untargeted Metabolomics, Targeted Metabolomics, and Lipidomics. Metabolon operates in a competitive market with competitors including Maze Therapeutics, Alector, Seer, Tango Therapeutics and NeoPhore, among others.
- Headquarter Morrisville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$165.87 M (USD)
in 19 rounds
-
Latest Funding Round
$7.5 M (USD), Series H
Dec 31, 2024
-
Investors
Sumitomo Corporation
& 14 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Lipomics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Metabolon
Metabolon offers a comprehensive portfolio of products and services, including Bioinformatics Platform, Untargeted Metabolomics, Targeted Metabolomics, and Lipidomics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tool for visualizing and analyzing metabolomics data sets
Analysis of wide-ranging metabolites for research
Quantification of specific metabolites for studies
Identification of lipid species in biological samples
Unlock access to complete
Sales and Marketing
16 people
Leadership Team
13 people
Data Analysis and Operations Team
6 people
Product Management Team
6 people
Senior Team
5 people
Principal Team
4 people
Finance and Accounting
3 people
Operations Team
2 people
Unlock access to complete
Funding Insights of Metabolon
Metabolon has successfully raised a total of $165.87M across 19 strategic funding rounds. The most recent funding activity was a Series H round of $7.5 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 19
- Last Round Series H — $7.5M
-
First Round
First Round
(01 Mar 2003)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series H - Metabolon | Valuation |
investors |
|
| May, 2024 | Amount | Grant - Metabolon | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Metabolon | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Metabolon
Metabolon has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include Sumitomo Corporation, ARE and East West Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified debt funding is provided for growth capital opportunities.
|
Founded Year | Domain | Location | |
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
Growth equity investments are made in lower middle market companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Metabolon
Metabolon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Lipomics and Metabolomic Discoveries. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Metabolomic data analysis software and services are provided for research.
|
2009 | ||||
|
Diagnostics for metabolic, cardiovascular, and inflammatory conditions are developed.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Metabolon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Metabolon Comparisons
Competitors of Metabolon
Metabolon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Maze Therapeutics, Alector, Seer, Tango Therapeutics and NeoPhore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| domain | founded_year | HQ Location |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Metabolon
Frequently Asked Questions about Metabolon
When was Metabolon founded?
Metabolon was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is Metabolon located?
Metabolon is headquartered in Morrisville, United States.
Is Metabolon a funded company?
Metabolon is a funded company, having raised a total of $165.87M across 19 funding rounds to date. The company's 1st funding round was a Grant of $297.67K, raised on Mar 01, 2003.
What does Metabolon do?
Metabolon was founded in 2000 and is headquartered in Morrisville, United States. Operations focus on the biotechnology sector, where a biochemical profiling platform is utilized to analyze and identify biochemicals for research in pharmaceuticals, biotech, agriculture, cosmetics, and consumer products. Services include Quantose IR for prediabetes assessment and Meta IMD for detecting inborn errors of metabolism. Development of metabolomics-based tests for early detection of obesity-related metabolic diseases is ongoing.
Who are the top competitors of Metabolon?
Metabolon's top competitors include Alector, Lexicon Pharmaceuticals and Maze Therapeutics.
What products or services does Metabolon offer?
Metabolon offers Bioinformatics Platform, Untargeted Metabolomics, Targeted Metabolomics, and Lipidomics.
How many acquisitions has Metabolon made?
Metabolon has made 2 acquisitions, including Lipomics, and Metabolomic Discoveries.
Who are Metabolon's investors?
Metabolon has 15 investors. Key investors include Sumitomo Corporation, ARE, East West Bank, HHS, and Fletcher Spaght.